CLICK HERE to learn more about Kineta's reverse merger with NASDAQ listed Yumanity Therapeutics (YMTX) announcement
Kineta Inc.
about
company
team
board
SAB
platform
pipeline
KVA12.1
CD27
KCP506
LHF535
partnering
investors
news
careers
contact
English
Korean
Biology – Platform Page
join our email list
English
English
Korean
English
English
Korean